Global DNA diagnostics market is anticipated to exhibit lucrative growth over the forecast period owing to increasing incidences of chronic, genetic, and infectious diseases. Rising R&D and innovative implementation of technology in the field of bioinformatics coupled with rise in patented research initiatives by the government is anticipated to drive this industry through the forecast period.
Rising emphasis on early disease detection and prevention coupled with demand in pharmacogenomics and cancer genetic testing is anticipated to boost sector progress over the forecast period. Physicians have higher inclination towards genetic testing to determine patient’s health at different stages of disease development and this is expected to fuel this sector’s growth in the coming years.
Access full research report:
Other factors that will influence demand in the coming years include growing demand of personalized medicine to treat chronic disorders that need HLA typing and nucleotide identification for therapy. Moreover, technological advancements that result in the development of more efficient novel products in detecting DNA sequences are anticipated to influence industry growth through to 2022.
Escalating demands for pre-natal screening and newborn testing in order to detect congenital abnormalities coupled with rise in biobanking services that also involve DNA diagnostics as a crucial step for personalized medicine attribute to the progress in this sector.
Request for TOC of this research report:
However, high cost involved in R&D pertaining to introduction of new techniques and their implementation is estimated to hamper industrial revenue generation to certain extent. Additionally, stringent government regulations pertaining to nucleotide prototyping instruments as well as unclear reimbursement structure are anticipated to act as a hindrance to the entry of new industry players.
DNA diagnostics industry can be segmented on the basis of product, application, technology, and end-use. Product-wise, this industry can be classified into instruments, isolation & purification kits, amplification kits, and software & services. Instruments accounted for the largest share owing to the availability of reliable and user-friendly instruments, their competitive pricing, and portability.
Browse more reports of this category by Grand View Research:
Software and services are anticipated to register significant growth in the coming years due to the innovative technology and algorithms that are being introduced in this segment. Furthermore, use of optimized simulation and search algorithms that limit the chances of errors are expected impact industry positively.
DNA diagnostics market can be categorized into PCR, microarray, in-situ hybridization, DNA sequencing, fingerprinting, and mass spectrometry. Fingerprinting is further divided into fragment length polymorphism and polymerase chain reaction.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information, visit http://www.grandviewresearch.com/
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
Country: United States